Forty years ago, two researchers at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge developed a new technology that was to win him the Nobel Prize – and is now found in six out of ten of the world’s bestselling drugs. Dr Lara Marks from Department of History and Philosophy of Science discusses the importance of ‘monoclonal antibodies’.
A ‘brain training’ iPad game developed and tested by researchers at the University of Cambridge may improve the memory of patients with schizophrenia, helping them in their daily lives at work and living independently, according to research published today.
An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
A ‘pill on a string’ developed by researchers at the University of Cambridge could help doctors detect oesophageal cancer – cancer of the gullet – at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.
New report urges government and designers to work together to break down the barriers to innovation in order to adapt to an ageing population.
New report identifies six successful business models to guide companies.
A newly-designed material, which mimics the wing structure of owls, could help make wind turbines, computer fans and even planes much quieter. Early wind tunnel tests of the coating have shown a substantial reduction in noise without any noticeable effect on aerodynamics.
New funding will support fundamental research into the molecular processes underlying human disorders such as Alzheimer’s and Parkinson’s diseases, and enable new ways to combat them.
Europe's Graphene Flagship lays out a science and technology roadmap, targeting research areas designed to take graphene and related two-dimensional materials from academic laboratories into society.
The European alternative finance market - which includes crowdfunding, peer-to-peer lending and invoice trading - reached €3 billion last year and could top €7 billion in 2015, as businesses increasingly seek more efficient ways to raise funding.
Innovation is about the application of new ideas, discoveries and inventions. At the University of Cambridge, the recipe for success has been ingenuity and creativity, alongside the fundamental research that underpins these ideas, and combined with the constant exchange of ideas between academics and companies, governments and NGOs.
The "Cambridge Phenomenon" is a phrase internationally recognised which refers to the explosion of technology, life sciences and service companies in and around Cambridge. In 2010, we celebrated 50 years of the Cambridge Phenomenon; during this time we have seen it extend into the creative, educational and development sectors whilst still retaining a strong tradition of interaction with our academics across a myriad of disciplines. We are proud of the Cambridge cluster within which the University sits, our role within it and the contribution it has made - and continues to make - to society and the economy nationally and globally.”
Professor Lynn Gladden, Pro-Vice-Chancellor for Research
© 2015 University of Cambridge
